CLBIO.STCLBIO.STSTO

Revenue (LTM)

$8M

-21.7% YoY

Net Income (LTM)

$-15M

+36.6% YoY

Free Cash Flow

$-18M

Revenue CAGR (5Y)

+15.7%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	7	24↑233.5%	25↑6.3%	10↓60.9%	8↓21.7%
Gross Profit	9	23↑149.7%	28↑24.9%	13↓52.6%	-14↓205.7%
Operating Income	-7	2↑133.7%	-2↓176.8%	-23↓1195.6%	-14↑38.7%
Net Income	-7	2↑133.7%	-2↓177.7%	-23↓1182.1%	-15↑36.6%
EBITDA	-7	2↑134.7%	-2↓170.7%	-23↓1268.1%	-14↑38.8%
EPS Diluted	-0.34	0.11↑132.4%	-0.08↓175.9%	-1.06↓1169.5%	-0.59↑44.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	42	26↓37.0%	17↓35.1%	18↑3.9%	21↑16.3%
Total Current Assets	45	36↓19.7%	24↓33.9%	21↓11.6%	24↑14.0%
Total Assets	102	102↑0.1%	100↓1.6%	95↓5.3%	99↑4.0%
Total Current Liabilities	9	7↓23.7%	7↓5.6%	8↑15.6%	5↓38.6%
Total Liabilities	9	7↓23.7%	7↓5.6%	8↑15.6%	5↓38.6%
Total Equity	92	95↑2.6%	93↓1.3%	87↓6.9%	94↑7.9%
Total Debt	0	0	0	0	0
Net Debt	-42	-26↑37.0%	-17↑35.1%	-18↓3.9%	-21↓16.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-5	-6↓33.4%	1↑113.7%	-9↓1075.1%	-18↓104.8%
Capital Expenditure	-10	-9↑6.4%	-11↓18.0%	-7↑29.4%	-0↑99.4%
Free Cash Flow	-14	-15↓6.9%	-10↑37.0%	-16↓65.8%	-18↓9.9%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	33	-15↓147.1%	-9↑40.4%	1↑107.1%	3↑340.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance